Published in Clinical Oncology Week, June 26th, 2006
"We evaluated the usefulness of overexpression of NE cell differentiation determined by immunohistochemical staining for chromogranin A (Cg A) in diagnostic needle biopsy specimens of bone metastatic prostate cancers. A total of 50 patients diagnosed as having bone metastatic prostate cancer were studied," scientists in Japan reported.
"The period of observation was between 6.9 and 79.4 months (median 48.7 months)," explained Y. Yamada and colleagues, Aichi Medical University. "Cg A was detected by immunostaining using the labeled streptavidin...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.